Experience With Nintedanib in Severe Pulmonary Fibrosis Associated With Systemic Sclerosis: A Case Series

• Jaume Bordas-Martinez,
• Ana Belén Llanos-González,
• Ramon Jodar-Masanes,
• Vanesa Vicens-Zygmunt,
• Guadalupe Bermudo,
• Patricio Luburich,
• Jordi Dorca,
• Maria Molina-Molina,
• Guillermo Suarez-Cuartin

Affiliations

Jaume Bordas-Martinez

Unit of Interstitial Lung Disease, Respiratory Dpt., University Hospital of Bellvitge, IDIBELL, Hospitalet de Llobregat (Barcelona), Spain

Ana Belén Llanos-González

Respiratory Dpt., University Hospital Complex of the Canary Islands, Santa Cruz de Tenerife, Spain

Ramon Jodar-Masanes

Pharmacology Dpt., University Hospital of Bellvitge, IDIBELL, Hospitalet de Llobregat (Barcelona), Spain

Vanesa Vicens-Zygmunt

Unit of Interstitial Lung Disease, Respiratory Dpt., University Hospital of Bellvitge, IDIBELL, Hospitalet de Llobregat (Barcelona), Spain

Guadalupe Bermudo

Unit of Interstitial Lung Disease, Respiratory Dpt., University Hospital of Bellvitge, IDIBELL, Hospitalet de Llobregat (Barcelona), Spain

Patricio Luburich

Radiology Dpt., University Hospital of Bellvitge, IDIBELL, Hospitalet de Llobregat (Barcelona), Spain

Jordi Dorca

Unit of Interstitial Lung Disease, Respiratory Dpt., University Hospital of Bellvitge, IDIBELL, Hospitalet de Llobregat (Barcelona), Spain

Maria Molina-Molina

Unit of Interstitial Lung Disease, Respiratory Dpt., University Hospital of Bellvitge, IDIBELL, Hospitalet de Llobregat (Barcelona), Spain; Corresponding author.

Guillermo Suarez-Cuartin

Unit of Interstitial Lung Disease, Respiratory Dpt., University Hospital of Bellvitge, IDIBELL, Hospitalet de Llobregat (Barcelona), Spain